Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    20525995 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Condition: Myeloid Leukemia, Chronic
Interventions: Drug: Dasatinib;   Drug: Imatinib
2 Not yet recruiting Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia - Chronic Phase
Interventions: Drug: Dasatinib 100 MG [Sprycel];   Drug: Nilotinib 150mg oral capsule [Tasigna]
3 Recruiting Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis;   Untreated Adult Acute Myeloid Leukemia
Intervention: Drug: Nilotinib+AD induction

Study has passed its completion date and status has not been verified in more than two years.